- Help-Database
- Help-Advice
Dechra Profits Increase.
21st February 2012
Staffordshire based Dechra Pharmaceuticals plc has announced half year revenue of £209.5m to the 31st December 2011. This compares with £192m in 2010 and is as a result of two acquisitions of Genitrex and DermaPet as well as organic growth. An operating profit of £11m for the six month period shows a 10% growth. Dechra Pharmaceuticals' acquisitions have continued this year with the purchase of HY-50, an equine product from Bexinc. This product is expected to make a "small" contributiion to the second half earnings.
Sunday 20 May 2012
